Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Sirna Therapeutics and Allergan form strategic ophthalmology alliance

Oct. 3, 2005

Santen to develop rivoglitazone for corneal and conjunctival epithelial disorders

Sep. 30, 2005

Positive opinions in Europe for Combigan

Sep. 29, 2005

Macugen recommended for approval in Europe

Sep. 19, 2005

Biovitrum advances BVT-28949 into clinical testing for glaucoma

Sep. 15, 2005

Alcon patents superoxide dismutase mimics for optic nerve and retinal damage

Sep. 15, 2005

Genentech targets Lucentis BLA filing for December

Sep. 9, 2005

Mycophenolate mofetil shows promise in the treatment of inflammatory eye disease

Sep. 9, 2005

Recent Allergan patent reports new treatments for glaucoma

Sep. 7, 2005

Isis grants iCo license for ISIS-13650 for eye diseases

Aug. 29, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...